Novartis, an innovative medicines company, has announced plans to invest $23 billion over 5 years in U.S.-based ...

Arcutis Biotherapeutics Inc. has announced that David Topper, Arcutis’ chief financial officer (CFO) is retiring from the ...

Argenx’s VYVGART Hytrulo prefilled syringe for self-injection has received FDA approval for the treatment of adult patients ...